Skip to main content
Equibles

RHUMBLINE ADVISERS

Position in ASMB — Assembly Biosciences, Inc.

CIK 1115418 BOSTON, MA
Back to ASMB Full portfolio

Position in ASMB

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$318,493
+$313,221 QoQ
Shares Held
11,590
+6000.0% QoQ
Ownership
0.057%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#59
of 92 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority Sole 17% Shared 0% None 83%

Common Shares in ASMB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,414,750,230 across 329 Biotechnology names. ASMB ranks #216 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 396,380 $196,893,837
2 REGN
Regeneron Pharmaceuticals, Inc.
 157,794 $98,390,870
3 MRNA
Moderna, Inc.
 809,853 $56,714,005
4 ALNY
Alnylam Pharmaceuticals, Inc.
 165,579 $49,844,246
5 INCY
Incyte Corp
 428,533 $48,578,500
6 RVMD
Revolution Medicines, Inc.
 226,008 $42,326,778
7 ROIV
Roivant Sciences Ltd.
 1,178,789 $41,717,342
8 JAZZ
Jazz Pharmaceuticals plc
 163,018 $39,282,447

All Filings in ASMB

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $318,493 11,590
2026-03-31 $5,272 190
2025-12-31 $6,461 190
2025-09-30 $4,864 190
2025-06-30 $3,442 190
2025-03-31 $1,816 190
2024-12-31 $2,998 190
2024-09-30 $2,876 190
2024-06-30 $2,606 190
2024-03-31 $2,646 199
2023-12-31 $1,969 2,402
2023-09-30 $2,137 2,402
2023-06-30 $2,762 2,402
2021-03-31 $198,319 43,113
2020-12-31 $277,713 45,903
2020-09-30 $686,074 41,732
2020-06-30 $1,150,702 49,344
2020-03-31 $657,591 44,342